The PPARα synthetic agonist Wy-16434 has been shown to reverse dysbiosis induced by a high-fructose diet in the murine model of NAFLD, as well as in obese mice on HFD [53,54]. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.